UltraSound - Technology Information PortalTuesday, 21 February 2017
Info
  Sheets



Out-
      side
 




 
 'Amersham Health' 
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
Result : Searchterm 'Amersham Health' found in 1 term [] and 3 definitions [], (+ 1 Boolean[] results)
1 - 5 (of 5)     
Result Pages : [1]
US Resources  
Distributors - Kidney - Pregnancy - - Corporations - Patient Information
 
Amersham HealthMRI Resource Directory:<br> - Manufacturers -
 
www.amershamhealth.com

Amersham Health, now GE Healthcare was the imaging diagnostics and therapy business of Amersham plc. The imaging business produced contrast agents that are injected into the body to improve pictures obtained through medical imaging scans.

Contact Information:
MAIL Amersham Health
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA
UNITED KINGDOM
PHONE +44 (0) 1494-544000
FAX +44 (0) 1494-542266
ONLINE www.amershamhealth.com
CONTACT INFO PAGE www.amershamhealth.com/contact/thanks.html
spacer
• Related Searches:
    • Linear Scattering
    • ACUSON Sequoia Echo C512
    • Acoustic Lens
    • Mosaic Pattern
    • Obstetric and Gynecologic Ultrasound

Searchterm 'Amersham Health' was also found in the following service: 
spacer
Radiology  (2) Open this link in a new windowMRI  (7) Open this link in a new window
Amersham plcMRI Resource Directory:<br> - Manufacturers -
 
www.amersham.com

The British company is a producer of contrast-imaging agents used to enhance image quality in X-ray, magnetic resonance imaging, and ultrasound procedures. It is also a leading producer of radiopharmaceuticals used in nuclear medicine imaging. Amersham Health is the firm's imaging, diagnostics, and therapeutics segment. Amersham is involved in biotechnology research through its Amersham Biosciences unit, which makes scanners, sequencers, microarrays, industrial separations, and other research supplies.

Contact Information:
MAIL Amersham plc
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA
UNITED KINGDOM
PHONE +44-1494-544-000
FAX +44-1494-542-266
E-MAIL
ONLINE www.amersham.com
CONTACT INFO PAGE www.amersham.com/contact.html
spacer

US Resources  
Thyroid - Renal - Rental - Manufacturers - Service and Repair - Gall Bladder
 
GE HealthcareMRI Resource Directory:<br> - Manufacturers -
 
www.gehealthcare.com

GE Healthcare is the result of the merger between GE Medical and Amersham Health in Nov. 2004, after GE acquired Amersham Health for 9.5 billion in Oct. 2003. Jeffrey R. Immelt, Chairman of the Board and Chief Executive of General Electric, said, 'Amersham's diagnostic pharmaceutical and life sciences business will add new, high growth platforms to GE Medical's diagnostic imaging, services and health care information technology businesses'. GE Healthcare, a UK company, is a unit of General Electric (NYSE: GE). GE Healthcare is a global leader in medical imaging, diagnostic imaging agents, interventional procedures, health care services, and information technology. For more than 100 years, health care providers have relied on GE Medical Systems, now GE Healthcare, for high quality medical technology and productivity solutions. GE Healthcare, headquartered now at the formerly seat of Amersham Healthcare in Great Britain, operates facilities around the world. Global Operations include organizations on the Americas, Europe, and Asia, including India, Japan, Korea China, Thailand and Vietnam

Ultrasound Related Product Lines:
Ultrasound Systems:
LOGIQ 3 LOGIQ 5
LOGIQ® 7 LOGIQ® 9
Voluson 730 Expert LOGIQ Book XP
Vivid 7 Dimension Vivid i
Vivid 4 Vivid 3

Contrast Agents:
TRADE NAME FOR SALE FOR SALE /
DEVELOPMENT
DEVELOPMENT
Sonazoid®
Optison™

Contact Information:
ONLINE www.gehealthcare.com
CONTACT INFO PAGE www.gehealthcare.com/contact
spacer

• View the news results for 'GE Healthcare' (15).



 Further Reading:
  News & More:
Nycomed Amersham and Mallinckrodt Agree on Ultrasound Patent Settlement and Announce Joint Development of Existing Ultrasound ProductsOpen this link in a new window
   by www.prnewswire.com    
IMCOR Pharmaceutical Co., Alliance Pharmaceutical Corp., Molecular Biosystems, Inc. and GE Healthcare Ltd., Inc. Enter Into Cross-Licensing Agreement for Ultrasound Contrast PatentsOpen this link in a new window
   by www.prnewswire.com    
US Resources  
Heart - UltraSound Technician and Technologist Schools - Developers - Journals - Non-English - UltraSound Training Courses
 
Sonazoid™InfoSheet: - Contrast Agents - 
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:<br> - Contrast Agents -
 
Sonazoid™ is an ultrasound contrast agent (UCA) consisting of stabilized gas microbubbles in an aqueous suspension. Sonazoid™ has overcome the stability problems of first generation USCA and can produce myocardial perfusion images. Myocardial imaging using ultrasound contrast agents provides diagnosis of chronic heart disease and assessment of the coronary arteries and of the coronary blood flow reserve.
Sonazoid™ is taken up by healthy Kupffer cells in the liver and spleen, but break down in high amplitude ultrasound imaging modes such as color Doppler imaging. The bubble rupture produces a transient pressure wave, which results in a characteristic mosaic color pattern from tissues containing the microbubbles (induced acoustic emission). Liver tumors without Kupffer cells will not display the mosaic pattern and can therefore be identified easily.

Drug Information and Specification:
RESEARCH NAME NC100100
DEVELOPER Amersham Health
INDICATION -
DEVELOPMENT STAGE
Development in USA and EU suspended
APPLICATION -
TYPE Microbubble
SHELL Lipid Stabilized (not disclosed)
CHARGE Negative
GAS Perfluorobutane
MICROBUBBLE SIZE -
PRESENTATION -
STORAGE -
PREPARATION Reconstitute with 2mL water
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!

spacer

Searchterm 'Amersham Health' was also found in the following service: 
spacer
Radiology  (2) Open this link in a new windowMRI  (7) Open this link in a new window
Optison™InfoSheet: - Contrast Agents - 
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:<br> - Contrast Agents -
 
From GE Healthcare;;
Optison is the first 'second generation USCA' marketed in the US.
Ultrasound contrast agents used during an ultrasound imaging procedure, enable more accurate diagnosis of the patient's heart condition. The application of Optison allows to image the endocardial borders of the heart, to see cardiac wall motion abnormalities and to guide the selection and monitoring of treatment.
Optison represents a class of microbubbles with a shell formed by sonicating a solution of capsules filled with a perfluoropropane gas. The high molecular weight slows microbubble dissolution and prolongs the enhancement for several minutes. The human albumin-stabilized cavitation bubbles have a surface tension of 0.9 N/m and a surface dilatational viscosity 0.08 msP.

"August 06, 2001 Molecular Biosystems Inc., a subsidiary of Alliance Pharmaceutical Corp, announced the amendment of the Optison Product Rights Agreement (OPRA) dated May 9, 2000 with Mallinckrodt Inc, a unit of Tyco Healthcare. Optison, an intravenous ultrasound contrast agent, was developed by MBI and is being marketed by Mallinckrodt in the U.S. and Europe. Under the amended agreement, MBI will receive an immediate cash payment plus additional unspecified royalties for a two-year period. The amendment of OPRA coincides with an announcement by Nycomed Amersham Imaging that Nycomed and Mallinckrodt will terminate their joint commercialization and development agreement for ultrasound contrast agents, including Optison, effective Dec. 31, 2001. Effective Jan. 1, 2002, all selling and marketing activities will be resumed solely by Nycomed Amersham." (by EDGAR Online)

Drug Information and Specification:
RESEARCH NAME FS069
DEVELOPER Molecular Biosystems Inc.
INDICATION -
DEVELOPMENT STAGE
LVO -
For sale
APPLICATION intravenous/oral
TYPE microbubbles
SHELL Albumin N-acetyltryptophan, Caprylic acid
CHARGE Slight Negative
GAS Octafluoropropane
MICROBUBBLE SIZE 93% < 10µm
PRESENTATION Five 3 ml vials
STORAGE Refrigerate 2–8°C
PREPARATION Hand agitate
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!

Distribution Information:
TERRITORY DISTRIBUTOR
USA, EU GE Healthcare

spacer

 Further Reading:
  Basics:
Optison? Prescribing Information(.pdf)Open this link in a new window
  News & More:
CONTRAST ECHOCARDIOGRAPHY: NEW AGENTSOpen this link in a new window
   by eurheartj.oxfordjournals.org    
molecular imaging using ultrasoundOpen this link in a new window
   by bjr.birjournals.org    
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in EchocardiographyOpen this link in a new window
November 2008   by www.asecho.org    
Nycomed Amersham and Mallinckrodt Agree on Ultrasound Patent Settlement and Announce Joint Development of Existing Ultrasound ProductsOpen this link in a new window
   by www.prnewswire.com    
US Resources  
Rental - Ultrasound Gel - UltraSound Technician and Technologist Jobs - Portable UltraSound - Software - Vascular
 
Related Searches:
 • Hitachi Medical Systems America Inc.(USA)/Hitachi Medical Corp.(Tokyo)
 • ALOKA SSC-210Vet
 • EnVisor C
 • Transurethral Sonography
 • Guerbet S.A.
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
     1 - 5 (of 5)     
Result Pages : [1]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

US-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  


Look
      Ups



UltraSound - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • The-Medical-Market
Copyright © 2006 - 2016 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2015-03-04 09:17:02]